Argenx Se ADR (NQ: ARGX )
525.00
+0.10
(+0.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Argenx Se ADR
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
![](/next-assets/images/schema-image-default.png)
5 Analysts Have This to Say About argenx
March 03, 2023
Via Benzinga
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
From argenx SE
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For argenx
March 01, 2023
Via Benzinga
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
argenx Appoints Steve Krognes to Board of Directors
February 27, 2023
From argenx SE
Via GlobeNewswire
Analyst Ratings for argenx
January 10, 2023
Via Benzinga
Analyst Ratings for argenx
December 07, 2022
Via Benzinga
Expert Ratings for argenx
December 07, 2022
Via Benzinga
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
argenx to Present at Upcoming Investor Conferences
February 27, 2023
From argenx SE
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/02/15/imvt_logo_light__bd91b615149c51a39665ed629443a4ea.png?width=1200&height=800&fit=crop)
Immunovant Could Potentially Be An M&A Target, Writes Analyst
February 15, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/12/Stock-DrugDesigner-01-adobe.jpg)
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
From argenx SE
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/01/10/image-att_new.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
From argenx SE
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
argenx to Present at 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From argenx SE
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/12/22/image-google.jpg?width=1200&height=800&fit=crop)
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
argenx Appoints Ana Cespedes to Board of Directors
December 12, 2022
From argenx SE
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/blue_logo_light__1624b39f83a9fa5bb91803f2d607e59a.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22686.jpeg?width=1200&height=800&fit=crop)
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
argenx Enters Into Agreement To Acquire Priority Review Voucher
November 30, 2022
From argenx SE
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/22/argx_logo_light__4922bcd7bc515a6ab1f31330f48d1c5d.png?width=1200&height=800&fit=crop)
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
argenx to Present at Upcoming Investor Conferences
November 07, 2022
From argenx SE
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/10/28/image-mcdonalds.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9006.jpeg?width=1200&height=800&fit=crop)
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
From argenx SE
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.